Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Journal of Inorganic Biochemistry|June 5, 2012
Structural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: the importance of pKa matchingTimothy W Failes, Andrew R Battle, Catherine Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033Donna S Dorow, Carleen Cullinane, Nelly Conus, et al.
Nuclear Medicine and Biology|December 17, 2013
Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901Carleen Cullinane, Kelly L Waldeck, David Binns, et al.
Plos One|November 25, 2010
Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancerDariush Etemadmoghadam, Joshy George, Prue A Cowin, et al.
Bioconjugate Chemistry|August 20, 2015
New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.)Michelle T Ma, Carleen Cullinane, Cinzia Imberti, et al.
Dalton Transactions (Cambridge, England : 2003)|May 13, 2025
A gallium fluoride-18 complex containing a pentadentate macrocyclic ligand with a dimethylaminostilbene functional group designed for diagnostic imaging of Alzheimer's diseaseHuiJing Koay, Mohammad B Haskali, Jessica Van Zuylekom, et al.
Cancer Research|November 4, 2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug developmentCarleen Cullinane, Donna S Dorow, Maya Kansara, et al.
EJNMMI Radiopharmacy and Chemistry|November 26, 2024
Preclinical evaluation and automated synthesis of [89Zr]ZrDFOSquaramide-girentuximab for diagnostic imaging of carbonic anhydrase IX positive tumoursAsif Noor, Emily R McGowan, Jessica K Van Zuylekom, et al.
Molecular Cancer Therapeutics|June 3, 2011
In vivo activity of combined PI3K/mTOR and MEK inhibition in a Kras(G12D);Pten deletion mouse model of ovarian cancerKathryn M Kinross, Daniel V Brown, Margarete Kleinschmidt, et al.
Journal for Immunotherapy of Cancer|June 15, 2018
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitorsEdward Hammond, Nicole M Haynes, Carleen Cullinane, et al.
Pageof 11